Category: by country

“False” results in retracted paper by senator are inaccurate, not fraudulent, say editors

Daniel Biss

Last week, we wrote about a somewhat remarkable retraction, of a 15-year-old paper by a current Illinois senator who used to be a mathematician. At the time, we were a bit perplexed by the language of the notice, which the senator — who helpfully took our call — couldn’t answer, since he wasn’t involved in drafting the notice.

We’ve since heard back from the journal that retracted the paper, which explained that their phrase that “most results are false” meant the findings by state senator Daniel Biss were inaccurate — not fraudulent.

Here’s more explanation from a joint statement sent to us by Jan van Mill and Jerry Vaughan, the editors in chief of Topology and its Applications:

Continue reading “False” results in retracted paper by senator are inaccurate, not fraudulent, say editors

Researcher loses biotech post after reportedly confessing to fraud

A researcher has lost his position as a Chief Scientific Officer at a DNA sequencing company after he reportedly confessed to fabricating data in a 2015 paper, now retracted by the Journal of Cell Biology.

According to the CEO of Karmagenes, when the company learned about the retraction, the staff “immediately” conferred and decided the researcher — Pranav Ullal — should no longer serve as one of the company’s two CSOs.

Karmagenes CEO Kyriakos Kokkoris told us:

Continue reading Researcher loses biotech post after reportedly confessing to fraud

A new reproducibility fix? Get your work checked before it’s published

Jeffrey Mogil
Malcolm Macleod

Most researchers by now recognize there’s a reproducibility crisis facing science. But what to do about it? Today in Nature, Jeffrey S. Mogil at McGill University and Malcolm R. Macleod at the University of Edinburgh propose a new approach: Restructure the reporting of preclinical research to include an extra “confirmatory study” performed by an independent lab, which verifies the findings before they are published. We spoke with them about how this could work.

Retraction Watch: You’re proposing to restructure animal studies of new therapies or ways to prevent disease. Can you explain what this new type of study should look like, and how researchers will execute it?

Continue reading A new reproducibility fix? Get your work checked before it’s published

Former postdoc admitted to fraud in cell bio paper, lead author says

A researcher in Switzerland has retracted her 2015 paper in the Journal of Cell Biology, saying the first author — her former postdoc — admitted to fabricating multiple aspects of the paper.

After Sophie Martin of the University of Lausanne couldn’t reproduce the data from another manuscript she was preparing to submit, she contacted her former student, Pranav Ullal, who admitted he had fabricated the data, along with two figures in the JCB paper.

A spokesperson for the University of Lausanne told us that Ullal left Switzerland after his contract was over, and is now in India.

Martin told us the whole experience has been upsetting:

Continue reading Former postdoc admitted to fraud in cell bio paper, lead author says

Got “significosis?” Here are the five diseases of academic publishing

John Antonakis

John Antonakis is psychologist by training, but his research has run the gamut from showing kids accurately predict election outcomes just by looking at candidates’ faces to teaching charisma to people in leadership positions. Now, as the newly appointed editor of The Leadership Quarterly, he’s tackling problems in academic publishing. But his approach is somewhat unique – he sees these problems as diseases (ie, “significosis”) that threaten the well-being of the academic literature. In a new paper, he’s calling on the efforts of researchers, editors, and funders to prevent, diagnose, and treat the five diseases of academic publishing.

Retraction Watch: What prompted you to think about problems in science publishing in terms of diseases? 

Continue reading Got “significosis?” Here are the five diseases of academic publishing

“I placed too much faith in underpowered studies:” Nobel Prize winner admits mistakes

Daniel Kahneman

Although it’s the right thing to do, it’s never easy to admit error — particularly when you’re an extremely high-profile scientist whose work is being dissected publicly. So while it’s not a retraction, we thought this was worth noting: A Nobel Prize-winning researcher has admitted on a blog that he relied on weak studies in a chapter of his bestselling book.

The blog — by Ulrich Schimmack, Moritz Heene, and Kamini Kesavan — critiqued the citations included in a book by Daniel Kahneman, a psychologist whose research has illuminated our understanding of how humans form judgments and make decisions and earned him half of the 2002 Nobel Prize in Economics.

According to the Schimmack et al blog, Continue reading “I placed too much faith in underpowered studies:” Nobel Prize winner admits mistakes

Paper quickly retracted after author used another group’s work

The author of a 2016 paper has agreed to retract it after an investigation revealed that most of the article came from another research group at the same university.

According to the notice, the author based the majority of his paper on results generated by other scientists without their permission.

Here’s the retraction notice for “Controlled synthesis of magnetic block copolymers for anti-microbial purpose,” published in the Journal of Applied Polymer Science in November and retracted in February: Continue reading Paper quickly retracted after author used another group’s work

Unusual: Neurology removes author dinged for misconduct from 2016 paper

Neurology has partially retracted a 2016 paper, replacing a figure and removing the author who contributed it after he was found guilty of misconduct.

The journal has replaced the figure with a new one that confirmed the findings of the original, and swapped the name of Andrew Cullinane with the scientist who constructed the new figure using a new dataset. Last year, the U.S. Office of Research Integrity declared that Cullinane had falsified data in this paper and one other while working as a postdoctoral fellow in the Medical Genetics Branch at the National Human Genome Research Institute (NHGRI).

Cullinane appears to be at Howard University in Washington D.C., according to his LinkedIn page. He is listed as an assistant professor in the Basic Sciences/Anatomy department of the university’s College of Medicine.

Here’s the partial retraction notice from the journal:

Continue reading Unusual: Neurology removes author dinged for misconduct from 2016 paper

Cancer biologist stops research as his retraction count rises to 13

Anil Jaiswal

A cancer biologist based at the University of Maryland is transitioning out of research, as a journal has retracted three more of his papers.

Anil Jaiswal has now lost 13 papers, including, as we reported on February 6, six retractions issued earlier this month.

The Baltimore Sun reported this week that Jaiswal would no longer be conducting research at the University of Maryland School of Medicine, which we confirmed from a spokesperson:

Continue reading Cancer biologist stops research as his retraction count rises to 13

“Social science isn’t definitive like chemistry:” Embattled food researcher defends his work

Brian Wansink

It’s been a busy few months for Brian Wansink, a prominent food researcher at Cornell University. A blog post he wrote in November prompted a huge backlash from readers who accused him of using problematic research methods to produce questionable data, and a group of researchers suggested four of his papers contained 150 inconsistencies. The scientist has since announced he’s asked a non-author to reanalyze the data — a researcher in his own lab. Meanwhile, criticisms continue to mount. We spoke with Wansink about the backlash, and how he hopes to answer his critics’ questions.

Retraction Watch: Why not engage someone outside your lab to revalidate the analysis of the four papers under question? 

Continue reading “Social science isn’t definitive like chemistry:” Embattled food researcher defends his work